Webley WC, Norkin LC, Stuart ES.  2004.  Caveolin-2 associates with intracellular chlamydial inclusions independently of caveolin-1.. BMC Infect Dis. 4:23.

Webley WC, Vora GJ, Stuart ES.  2004.  Cell surface display of the chlamydial glycolipid exoantigen (GLXA) demonstrated by antibody-dependent complement-mediated cytotoxicity.. Curr Microbiol. 49(1):13-21.

Stuart ES, Webley WC, Norkin LC.  2003.  Lipid rafts, caveolae, caveolin-1, and entry by Chlamydiae into host cells.. Exp Cell Res. 287(1):67-78.

Mukherjee J, Chios K, Fishwild D, Hudson D, O'Donnell S, Rich SM, Donohue-Rolfe A, Tzipori S.  2002.  Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.. Infect Immun. 70(2):612-9.

Mukherjee J, Chios K, Fishwild D, Hudson D, O'Donnell S, Rich SM, Donohue-Rolfe A, Tzipori S.  2002.  Production and characterization of protective human antibodies against Shiga toxin 1.. Infect Immun. 70(10):5896-9.

Norkin LC, Wolfrom SA, Stuart ES.  2001.  Association of caveolin with Chlamydia trachomatis inclusions at early and late stages of infection.. Exp Cell Res. 266(2):229-38.